Related Experiment Videos
Peripheral neuropathy in patients with beta-thalassaemia
D A Papanastasiou1, D Papanicolaou, A M Magiakou
1University of Patras Medical School, Regional University Hospital of Patras, Greece.
Journal of Neurology, Neurosurgery, and Psychiatry
|November 1, 1991
Summary
Beta-thalassaemia patients often develop peripheral neuropathy, affecting nerves in the lower limbs. This condition, characterized by sensory and motor impairments, is detectable through clinical and electrophysiological tests.
Area of Science:
- Neurology
- Hematology
- Clinical Electrophysiology
Background:
- Beta-thalassaemia is a genetic blood disorder.
- Neurological manifestations are observed in some beta-thalassaemia patients.
- Peripheral neuropathy can affect quality of life.
Purpose of the Study:
- To investigate neurological signs in beta-thalassaemia patients.
- To determine the prevalence and characteristics of peripheral neuropathy in this population.
- To correlate clinical findings with electrophysiological data.
Main Methods:
- Clinical examinations were performed on 53 beta-thalassaemia patients and 29 healthy controls.
- Electrophysiological studies included nerve conduction velocity (NCV) and electromyography (EMG).
- Assessment focused on peripheral sensorimotor neuropathy, particularly in the lower limbs.
Main Results:
- Twenty percent of beta-thalassaemia patients exhibited mild peripheral sensorimotor neuropathy.
- Common symptoms included numbness, tingling, cramps, myalgia, and weakness.
- Electrophysiological findings revealed decreased motor conduction velocity and prolonged F-wave latencies in tibial and peroneal nerves.
Conclusions:
- A significant subset of beta-thalassaemia patients develop peripheral neuropathy.
- Neuropathy typically manifests in the second and third decades of life.
- Early detection and management of neuropathy are crucial for beta-thalassaemia patients.